$111.59
Price
$193.1B
Market Cap
37.0
P/E Ratio
18.4
Forward P/E
$3.02
EPS (TTM)
2.21%
Dividend Yield
$5.6B
Cash
$13.9B
Total Debt
1.73B
Shares Out
$81.97
$137.49
52-Week Range
Institutional Ownership of Abbott Laboratories
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 840.7K | $76M | $90.49 | +23.32% | ||
| 11.5K | $1M | — | — |
Trading Activity for Abbott Laboratories
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | NEW | 840.7K | $76M | $90.49 | |
| 2024-Q2 | |||||
| SELL | -0.9% | 11.5K | $1M | $105.49 | |
| 2023-Q2 | |||||
| SELL | -1.4% | 11.6K | $1M | $106.70 | |
| 2022-Q2 | |||||
| SELL | -4.1% | 11.8K | $1M | $114.54 | |
| 2021-Q3 | |||||
| BUY | +2.5% | 12.3K | $1M | $122.81 | |
| 2020-Q3 | |||||
| BUY | +1.4% | 12.0K | $1M | $101.23 | |
| 2020-Q1 | |||||
| SELL | -2.5% | 11.8K | $932000 | $85.89 | |
| 2019-Q1 | |||||
| SELL | -13.2% | 12.1K | $968000 | $75.00 | |
| SELL | EXIT | — | — | $75.00 | |
| 2018-Q3 | |||||
| BUY | NEW | 2.8K | $205000 | $65.23 | |
| 2018-Q2 | |||||
| BUY | +9.1% | 14.0K | $851000 | $60.77 | |
Insider Trading for Abbott Laboratories
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.